Cholinesterase inhibitor, indicated for the symptomatic treatment of mild to moderately severe Alzheimer’s type dementia.

Alzheimer’s type dementia is believed to be related to the lack of acetylcholine, a substance responsible for messages’ transmission between brain cells.

MEMOTON-LIFE® increases the amount of acetylcholine in the brain and so improves the symptoms of the disease (gradual loss of memory, increasing confusion and changes in behavior).

DRUG ACTIVE SUBSTANCE CONTENT PHARMACEUTICAL FORM       PACKAGING THERAPEUTICAL CATEGORY
Galantamine 4 mg/mL Oral solution FL x 100 mL Cholinesterase inhibitor, for the symptomatic treatment of mild to moderately severe Alzheimer’s type dementia

 

DRUG ACTIVE SUBSTANCE CONTENT PHARMACEUTICAL FORM       PACKAGING THERAPEUTICAL CATEGORY
Aciclovir 5% Cream Tube x 10 g Anti-viral cream for herpes virus treatment